Literature DB >> 9256672

Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior.

L J Burak1, M Meyer.   

Abstract

The high prevalence of human papillomavirus (HPV) among adolescent and young adult women and the causal association between certain types of HPV and cervical cancer make regular gynecological screening and Pap smear testing essential health practices for young women. In this study, we used the constructs of the Health Belief Model (HBM) to examine the gynecological screening beliefs and behaviors of a sample of 400 college women. Although the constructs of the model were able to explain only 15% of the variance in screening behavior and 11% of screening intentions, the use of the HBM framework resulted in important information regarding the participants' beliefs.

Entities:  

Mesh:

Year:  1997        PMID: 9256672     DOI: 10.1080/07399339709516279

Source DB:  PubMed          Journal:  Health Care Women Int        ISSN: 0739-9332


  11 in total

1.  Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.

Authors:  Jennifer M Matro; Karen J Ruth; Yu-Ning Wong; Katen C McCully; Christina M Rybak; Neal J Meropol; Michael J Hall
Journal:  J Genet Couns       Date:  2014-05-06       Impact factor: 2.537

2.  Perceived risk of cervical cancer in Appalachian women.

Authors:  Kimberly M Kelly; Amy K Ferketich; Mack T Ruffin Iv; Cathy Tatum; Electra D Paskett
Journal:  Am J Health Behav       Date:  2012-11

3.  [Human papilloma virus: knowledge, beliefs and behavior of Quebec women].

Authors:  Marilou Kiely; Chantal Sauvageau; Eve Dubé; Geneviève Deceuninck; Phillippe De Wals
Journal:  Can J Public Health       Date:  2011 Jul-Aug

4.  Rural-Urban Differences in Colorectal Cancer Screening Barriers in Nebraska.

Authors:  Alejandro G Hughes; Shinobu Watanabe-Galloway; Paulette Schnell; Amr S Soliman
Journal:  J Community Health       Date:  2015-12

5.  HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population.

Authors:  Monique A Tello; Hsin-Chieh Yeh; Jean M Keller; Mary C Beach; Jean R Anderson; Richard D Moore
Journal:  J Womens Health (Larchmt)       Date:  2008-12       Impact factor: 2.681

6.  Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.

Authors:  Susan T Vadaparampil; Stephanie A S Staras; Teri L Malo; Katie Z Eddleton; Juliette Christie; Maria Rodriguez; Anna R Giuliano; Elizabeth A Shenkman
Journal:  Cancer       Date:  2012-08-01       Impact factor: 6.860

7.  Factors Affecting Cervical Cancer Screening Behaviors Based On the Precaution Adoption Process Model: A Qualitative Study.

Authors:  Afshin Bahmani; Mohammah Hossein Baghianimoghadam; Behnaz Enjezab; Seyed Saeed Mazloomy Mahmoodabad; Mohsen Askarshahi
Journal:  Glob J Health Sci       Date:  2015-11-17

8.  Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in León, Nicaragua.

Authors:  Hannah D Rees; Alexandra R Lombardo; Caroline G Tangoren; Sara J Meyers; Vishnu R Muppala; Linda M Niccolai
Journal:  PeerJ       Date:  2017-10-25       Impact factor: 2.984

9.  Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women.

Authors:  Vincenzo Restivo; Claudio Costantino; Antonello Marras; Giuseppe Napoli; Sabrina Scelfo; Tiziana Scuderi; Alessandra Casuccio; Achille Cernigliaro; Angela Giusti; Stefania Spila Alegiani
Journal:  Int J Environ Res Public Health       Date:  2018-08-22       Impact factor: 3.390

10.  Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.

Authors:  Flora F Teng; Sheona M Mitchell; Musa Sekikubo; Christine Biryabarema; Josaphat K Byamugisha; Malcolm Steinberg; Deborah M Money; Gina S Ogilvie
Journal:  BMJ Open       Date:  2014-04-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.